Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Eli Lilly and Company
AstraZeneca
Kivu Bioscience Inc.
AstraZeneca
Mersana Therapeutics
Pfizer
Bristol-Myers Squibb
Genmab
Travera Inc
Eli Lilly and Company
Nammi Therapeutics Inc
Beijing Biotech
Regor Pharmaceuticals Inc.
Jazz Pharmaceuticals
Bayer
Exscientia AI Limited
Amgen
Genmab
Fate Therapeutics
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Incyclix Bio
Arcus Biosciences, Inc.
Sotio Biotech Inc.
858 Therapeutics, Inc.
Radiopharm Theranostics, Ltd
EMD Serono
Eli Lilly and Company
AstraZeneca
SystImmune Inc.
Terremoto Biosciences Inc.
Filamon LTD
Ensem Therapeutics
Atavistik Bio, Inc
Eisai Inc.
PMV Pharmaceuticals, Inc
AstraZeneca
NiKang Therapeutics, Inc.
NeoImmuneTech
Alterome Therapeutics, Inc.
Hoffmann-La Roche
BeOne Medicines
Convalife (Shanghai) Co., Ltd.
Eli Lilly and Company
ViroMissile, Inc.
Genmab
Accent Therapeutics
Carevive Systems, Inc.
AstraZeneca